Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

106 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and safety of treatment of chronic hepatitis C with sofosbuvir and ribavirin with or without peginterferon: a French prospective real-life cohort study of unselected 211 patients.
Garioud A, Heng R, Amiot X, Rémy AJ, Ollivier-Hourmand I, Mokhtari C, Medmoun M, Renou C, Zougmoré H, Pulwermacher P, Lucidarme D, Rosa-Hézode I, Causse X, Arotcarena R, Zanditenas D, Halfon P, Pariente A, Cadranel JF; Association Nationale des Hépato-gastroentérologues des Hôpitaux Généraux (ANGH), France. Garioud A, et al. Among authors: renou c. Eur J Gastroenterol Hepatol. 2019 Oct;31(10):1270-1274. doi: 10.1097/MEG.0000000000001450. Eur J Gastroenterol Hepatol. 2019. PMID: 31219848 Clinical Trial.
Treatment of chronic hepatitis C with pegylated interferon and ribavirin in treatment-naive patients in 'true life': a plea in favor of independent postmarketing evaluations.
Pariente A, Lahmek P, Duprat C, Denis J, Faroux R, Renou C, Nalet B, Morin T, Cadranel JF; Investigator Group belonging to Association Nationale des Gastroentérologues des Hôpitaux Généraux (ANGH). Pariente A, et al. Among authors: renou c. Eur J Gastroenterol Hepatol. 2010 Nov;22(11):1297-302. doi: 10.1097/meg.0b013e32833bb4b0. Eur J Gastroenterol Hepatol. 2010. PMID: 20964260
Hepatitis C treatment with all-oral direct-acting antivirals: Effectiveness and tolerance in a multicenter, prospective, observational study from French general hospitals (APROVVIE, ANGH).
Pariente A, Arpurt JP, Rémy AJ, Rosa-Hézode I, Causse X, Heluwaert F, Macaigne G, Henrion J, Renou C, Schnee M, Salloum H, Hommel S, Pilette C, Arotcarena R, Barjonet G, Lison H, Bourhis F, Jouannaud V, Pauwels A, Le eaBricquir Y, Geagea E, Condat B, Ripault MP, Zanditenas D, de Montigny-Lenhardt S, Labadie H, Tissot B, Maringe E, Cadranel JF, Hagège H, Lesgourgues B; Association nationale des gastroentérologues des hôpitaux (ANGH). Pariente A, et al. Among authors: renou c. Presse Med. 2019 Mar;48(3 Pt 1):e101-e110. doi: 10.1016/j.lpm.2018.06.019. Epub 2019 Mar 8. Presse Med. 2019. PMID: 30853287
Effects of Age on Treatment of Chronic Hepatitis C with Direct Acting Antivirals.
Pariente A, Arpurt JP, Remy AJ, Rosa-Hezode I, Causse X, Heluwaert F, Macaigne G, Henrion J, Renou C, Schnee M, Salloum H, Hommel S, Pilette C, Arotcarena R, Barjonet G, Lison H, Bourhis F, Jouannaud V, Pauwels A, Le-Bricquir Y, Geagea E, Condat B, Ripault MP, Zanditenas D, de Montigny-Lenhardt S, Labadie H, Tissot B, Maringe E, Cadranel JF, Hagege H, Lesgourgues B; Association Nationale des Gastroenterologues des Hopitaux (ANGH). Pariente A, et al. Among authors: renou c. Ann Hepatol. 2019 Jan-Feb;18(1):193-202. doi: 10.5604/01.3001.0012.7912. Ann Hepatol. 2019. PMID: 31113590 Free article.
A single IL28B genotype SNP rs12979860 determination predicts treatment response in patients with chronic hepatitis C Genotype 1 virus.
Halfon P, Bourliere M, Ouzan D, Maor Y, Renou C, Wartelle C, Pénaranda G, Tran A, Botta D, Oules V, Castellani P, Portal I, Argiro L, Dessein A. Halfon P, et al. Among authors: renou c. Eur J Gastroenterol Hepatol. 2011 Oct;23(10):931-5. doi: 10.1097/MEG.0b013e328349d0ef. Eur J Gastroenterol Hepatol. 2011. PMID: 21900787
Impact of IL28B on the treatment decision in naïve and experienced patients with genotype 1 and 4 chronic hepatitis C in real-life clinical practice: a prospective multicenter cohort.
Halfon P, Ouzan D, Asselah T, Renou C, Allègre T, Delasalle P, Lafeuillade A, Cadranel JF, Haddad N, Khiri H, Pénaranda G, Bourlière M; Iliade Investigators. Halfon P, et al. Among authors: renou c. Clin Res Hepatol Gastroenterol. 2014 Dec;38(6):720-6. doi: 10.1016/j.clinre.2014.06.004. Epub 2014 Jul 14. Clin Res Hepatol Gastroenterol. 2014. PMID: 25034356
Hepatogastroenterologists' knowledge of inactive carriers and immunotolerant hepatitis B virus patients in France: results of a practice survey.
Causse X, Cadranel JF, Potier P, Hanslik B, Denis J, Renou C, Delasalle P; Club de Réflexion des Cabinets et Groupes d’Hépato-Gastroentérologie (CREGG); Association Nationale des hépato-Gastroentérologues des Hôpitaux généraux de France (ANGH). Causse X, et al. Among authors: renou c. Eur J Gastroenterol Hepatol. 2015 May;27(5):544-9. doi: 10.1097/MEG.0000000000000306. Eur J Gastroenterol Hepatol. 2015. PMID: 25822863
Management of primary biliary cholangitis: results from a large real-life observational study in France and Belgium.
Pariente A, Chazouilleres O, Causse X, Hanslik B, Arpurt JP, Henrion J, Rosa I, Renou C, Garioud A, Corpechot C; DESCRIPT and DESCRIPT Study Groups. Pariente A, et al. Among authors: renou c. Eur J Gastroenterol Hepatol. 2021 Dec 1;33(1S Suppl 1):e197-e205. doi: 10.1097/MEG.0000000000002011. Eur J Gastroenterol Hepatol. 2021. PMID: 33252413
106 results